REPORT ID 2439

Asia-Pacific Nuclear Medicine Market Report 2019

Publish Date
2019
Pages
100
Format
Electronic (PDF)

In this report, the Asia-Pacific Nuclear Medicine market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Nuclear Medicine for these regions, from   2019 to 2025 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Nuclear Medicine market competition by top manufacturers/players, with Nuclear Medicine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Mallinckrodt
    Medtronic
    General Electric
    GlaxoSmithKline
    Cardinal Health
    Lantheus Medical Imaging
    IBA
    ...

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Diagnostic
    Therapeutic

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Oncology
    Cardiology
    Neurology
    Thyroid
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Nuclear Medicine Market  Report 2019
1 Nuclear Medicine Overview
    1.1 Product Overview and Scope of Nuclear Medicine
    1.2 Classification of Nuclear Medicine by Product Category
        1.2.1 Asia-Pacific Nuclear Medicine Market Size (Sales) Comparison by Types ( 2014-2024)
        1.2.2 Asia-Pacific Nuclear Medicine Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Diagnostic
        1.2.4 Therapeutic
    1.3 Asia-Pacific Nuclear Medicine Market by Application/End Users
        1.3.1 Asia-Pacific Nuclear Medicine Sales (Volume) and Market Share Comparison by Applications ( 2014-2024)
        1.3.2 Oncology
        1.3.3 Cardiology
        1.3.4 Neurology
        1.3.5 Thyroid
        1.3.6 Others
    1.4 Asia-Pacific Nuclear Medicine Market by Region
        1.4.1 Asia-Pacific Nuclear Medicine Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 China Status and Prospect ( 2014-2024)
        1.4.3 Japan Status and Prospect ( 2014-2024)
        1.4.4 South Korea Status and Prospect ( 2014-2024)
        1.4.5 Taiwan Status and Prospect ( 2014-2024)
        1.4.6 India Status and Prospect ( 2014-2024)
        1.4.7 Southeast Asia Status and Prospect ( 2014-2024)
        1.4.8 Australia Status and Prospect ( 2014-2024)
    1.5 Asia-Pacific Market Size (Value and Volume) of Nuclear Medicine ( 2014-2024)
        1.5.1 Asia-Pacific Nuclear Medicine Sales and Growth Rate ( 2014-2024)
        1.5.2 Asia-Pacific Nuclear Medicine Revenue and Growth Rate ( 2014-2024)

2 Asia-Pacific Nuclear Medicine Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Nuclear Medicine Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Nuclear Medicine Sales Volume and Market Share of Key Players/Suppliers ( 2014-2019)
        2.1.2 Asia-Pacific Nuclear Medicine Revenue and Share by Players/Suppliers ( 2014-2019)
    2.2 Asia-Pacific Nuclear Medicine (Volume and Value) by Type
        2.2.1 Asia-Pacific Nuclear Medicine Sales and Market Share by Type ( 2014-2019)
        2.2.2 Asia-Pacific Nuclear Medicine Revenue and Market Share by Type ( 2014-2019)
    2.3 Asia-Pacific Nuclear Medicine (Volume) by Application
    2.4 Asia-Pacific Nuclear Medicine (Volume and Value) by Region
        2.4.1 Asia-Pacific Nuclear Medicine Sales and Market Share by Region ( 2014-2019)
        2.4.2 Asia-Pacific Nuclear Medicine Revenue and Market Share by Region ( 2014-2019)

3 China Nuclear Medicine (Volume, Value and Sales Price)
    3.1 China Nuclear Medicine Sales and Value ( 2014-2019)
        3.1.1 China Nuclear Medicine Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 China Nuclear Medicine Revenue and Growth Rate ( 2014-2019)
        3.1.3 China Nuclear Medicine Sales Price Trend ( 2014-2019)
    3.2 China Nuclear Medicine Sales Volume and Market Share by Type
    3.3 China Nuclear Medicine Sales Volume and Market Share by Application

4 Japan Nuclear Medicine (Volume, Value and Sales Price)
    4.1 Japan Nuclear Medicine Sales and Value ( 2014-2019)
        4.1.1 Japan Nuclear Medicine Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Japan Nuclear Medicine Revenue and Growth Rate ( 2014-2019)
        4.1.3 Japan Nuclear Medicine Sales Price Trend ( 2014-2019)
    4.2 Japan Nuclear Medicine Sales Volume and Market Share by Type
    4.3 Japan Nuclear Medicine Sales Volume and Market Share by Application

5 South Korea Nuclear Medicine (Volume, Value and Sales Price)
    5.1 South Korea Nuclear Medicine Sales and Value ( 2014-2019)
        5.1.1 South Korea Nuclear Medicine Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 South Korea Nuclear Medicine Revenue and Growth Rate ( 2014-2019)
        5.1.3 South Korea Nuclear Medicine Sales Price Trend ( 2014-2019)
    5.2 South Korea Nuclear Medicine Sales Volume and Market Share by Type
    5.3 South Korea Nuclear Medicine Sales Volume and Market Share by Application

6 Taiwan Nuclear Medicine (Volume, Value and Sales Price)
    6.1 Taiwan Nuclear Medicine Sales and Value ( 2014-2019)
        6.1.1 Taiwan Nuclear Medicine Sales Volume and Growth Rate ( 2014-2019)
        6.1.2 Taiwan Nuclear Medicine Revenue and Growth Rate ( 2014-2019)
        6.1.3 Taiwan Nuclear Medicine Sales Price Trend ( 2014-2019)
    6.2 Taiwan Nuclear Medicine Sales Volume and Market Share by Type
    6.3 Taiwan Nuclear Medicine Sales Volume and Market Share by Application

7 India Nuclear Medicine (Volume, Value and Sales Price)
    7.1 India Nuclear Medicine Sales and Value ( 2014-2019)
        7.1.1 India Nuclear Medicine Sales Volume and Growth Rate ( 2014-2019)
        7.1.2 India Nuclear Medicine Revenue and Growth Rate ( 2014-2019)
        7.1.3 India Nuclear Medicine Sales Price Trend ( 2014-2019)
    7.2 India Nuclear Medicine Sales Volume and Market Share by Type
    7.3 India Nuclear Medicine Sales Volume and Market Share by Application

8 Southeast Asia Nuclear Medicine (Volume, Value and Sales Price)
    8.1 Southeast Asia Nuclear Medicine Sales and Value ( 2014-2019)
        8.1.1 Southeast Asia Nuclear Medicine Sales Volume and Growth Rate ( 2014-2019)
        8.1.2 Southeast Asia Nuclear Medicine Revenue and Growth Rate ( 2014-2019)
        8.1.3 Southeast Asia Nuclear Medicine Sales Price Trend ( 2014-2019)
    8.2 Southeast Asia Nuclear Medicine Sales Volume and Market Share by Type
    8.3 Southeast Asia Nuclear Medicine Sales Volume and Market Share by Application

9 Australia Nuclear Medicine (Volume, Value and Sales Price)
    9.1 Australia Nuclear Medicine Sales and Value ( 2014-2019)
        9.1.1 Australia Nuclear Medicine Sales Volume and Growth Rate ( 2014-2019)
        9.1.2 Australia Nuclear Medicine Revenue and Growth Rate ( 2014-2019)
        9.1.3 Australia Nuclear Medicine Sales Price Trend ( 2014-2019)
    9.2 Australia Nuclear Medicine Sales Volume and Market Share by Type
    9.3 Australia Nuclear Medicine Sales Volume and Market Share by Application

10 Asia-Pacific Nuclear Medicine Players/Suppliers Profiles and Sales Data
    10.1 Mallinckrodt
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Nuclear Medicine Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Mallinckrodt Nuclear Medicine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.1.4 Main Business/Business Overview
    10.2 Medtronic
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Nuclear Medicine Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Medtronic Nuclear Medicine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.2.4 Main Business/Business Overview
    10.3 General Electric
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Nuclear Medicine Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 General Electric Nuclear Medicine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.3.4 Main Business/Business Overview
    10.4 GlaxoSmithKline
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Nuclear Medicine Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 GlaxoSmithKline Nuclear Medicine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.4.4 Main Business/Business Overview
    10.5 Cardinal Health
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Nuclear Medicine Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Cardinal Health Nuclear Medicine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.5.4 Main Business/Business Overview
    10.6 Lantheus Medical Imaging
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Nuclear Medicine Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Lantheus Medical Imaging Nuclear Medicine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.6.4 Main Business/Business Overview
    10.7 IBA
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Nuclear Medicine Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 IBA Nuclear Medicine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.7.4 Main Business/Business Overview
    ...

11 Nuclear Medicine Manufacturing Cost Analysis
    11.1 Nuclear Medicine Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Nuclear Medicine

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Nuclear Medicine Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Nuclear Medicine Major Manufacturers  in 2018
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Nuclear Medicine Market Forecast ( 2019-2025)
    15.1 Asia-Pacific Nuclear Medicine Sales Volume, Revenue and Price Forecast ( 2019-2025)
        15.1.1 Asia-Pacific Nuclear Medicine Sales Volume and Growth Rate Forecast ( 2019-2025)
        15.1.2 Asia-Pacific Nuclear Medicine Revenue and Growth Rate Forecast ( 2019-2025)
        15.1.3 Asia-Pacific Nuclear Medicine Price and Trend Forecast ( 2019-2025)
    15.2 Asia-Pacific Nuclear Medicine Sales Volume, Revenue and Growth Rate Forecast by Region ( 2019-2025)
        15.2.1 Asia-Pacific Nuclear Medicine Sales Volume and Growth Rate Forecast by Region ( 2019-2025)
        15.2.2 Asia-Pacific Nuclear Medicine Revenue and Growth Rate Forecast by Region ( 2019-2025)
        15.2.3 China Nuclear Medicine Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.4 Japan Nuclear Medicine Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.5 South Korea Nuclear Medicine Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.6 Taiwan Nuclear Medicine Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.7 India Nuclear Medicine Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.8 Southeast Asia Nuclear Medicine Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.9 Australia Nuclear Medicine Sales, Revenue and Growth Rate Forecast ( 2019-2025)
    15.3 Asia-Pacific Nuclear Medicine Sales, Revenue and Price Forecast by Type ( 2019-2025)
        15.3.1 Asia-Pacific Nuclear Medicine Sales Forecast by Type ( 2019-2025)
        15.3.2 Asia-Pacific Nuclear Medicine Revenue Forecast by Type ( 2019-2025)
        15.3.3 Asia-Pacific Nuclear Medicine Price Forecast by Type ( 2019-2025)
    15.4 Asia-Pacific Nuclear Medicine Sales Forecast by Application ( 2019-2025)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer